The drug-induced injury of the upper gastrointestinal tract: prophylaxis and treatment
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
It is well established that non-steroidal anti-inflammatory drugs (NSAIDs) are the causal factor of mucosa damage not only of in the stomach and duodenum, but also in esophagus, triggering the development of gastroesophageal reflux disease (GERD). It is known that NSAIDs’ intake (including low doses of aspirin) can significantly increase the likelihood of developing of the peptic esophagitis with the risk of ulceration, bleeding, or stricture formation. Recent years, there is an increasing number of papers, devoted to the investigation of esophageal lesions and mechanisms of GERD development, occurring during the NSAIDs’ administration (including low doses of acetylsalicylic acid) and other drugs. The structure of drug-induced lesions of the upper gastrointestinal tract in patients taking NSAIDs has been analyzed. The investigation has been performed to study the frequency and characteristics of esophageal lesions in patients with osteoarthrosis of large joints, receiving NSAID treatment, as well as to determine factors that increase risk of developing this pathology. With account of the considered risk factors, the most rational approach to the diagnosis and primary prevention of NSAID-induced esophagitis has been chosen, which in most cases should reduce the incidence of side effects of NSAID-associated lesions of the esophagus. The main directions in the treatment of NSAID-associated injuries of the esophagus, namely, lifestyle change, balanced diet, changing the dose and regimen of NSAIDs or switching to selective NSAIDs, modern pharmacotherapy and surgical treatment have been elucidated. Clinical examples of patients with esophagus and stomach injuries associated with the long-term administration of NSAIDs and antiplatelet drugs were used to discuss the prevention and treatment of this category of patients, using proton pump inhibitors and bismuth-containing drugs.
Authors and Affiliations
O. O. Bondarenko, O. M. Agibalov
Keywords
Related Articles
- EP ID EP575132
- DOI 10.30978/MG-2019-2-55
- Views 113
- Downloads 0
The post-infection syndrome of the irritable bowel: recent recommendations of the Rome Foundation Working team
The presence of such form of the irritable bowel syndrome (IBS) as a post-infection IBS (PI — IBS) was proved a long time ago in the clinical-laboratory and epidemiological investigations, conducted in various geographic...
The evaluation of specific changes and diagnostic informativeness of the cytokine profile in young patients with gastroesophageal reflux disease, occurring against the background of autoimmune inflammation
Objective — to determine the general trend of changes in the indicators of systemic inflammation — interleukin-1β and interleukin-18, in young patients with gastroesophageal reflux disease (GERD) and autoimmune thyroidit...
Non-invasive diagnosis of non-alcoholic fatty liver disease: the available opportunities we have today
Non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly common disease, it is currently diagnosed in more than a quarter of adult population worldwide, and its portion in the overweight patients with type 2...
The dynamics of results of the esophageal 24-hour multichannel intraluminal impedance-pH monitoring in patients with stable angina and gastroesophageal reflux disease against the background of the basic treatment correction
Due to the mutual aggravating effects in the comorbidity of the stable angina of effort (SAE) and gastroesophageal reflux disease (GERD), the necessity arises for the correction of basic therapy of each of these patholog...
A clinical case of rare vascular lesion of the large intestine
The article presents a clinical case of a hemangioma of the large intestine. The patient was observed for ulcerative colitis and hemorrhoidal hemorrhages for a long time and received appropriate treatment. Performing a s...